Feverfew
A centuries-old herbal remedy with genuine, though modest, clinical research behind its use as a daily preventive for migraine headaches.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your physician before starting any supplement.
Feverfew (Tanacetum parthenium) is a daisy-like flowering plant with a long history of traditional use in Europe, originally for fevers (hence the name), inflammation, and headaches. Its modern reputation rests almost entirely on migraine prevention, an area where it has actual clinical trial data behind it — a relative rarity among traditional herbs marketed for headache relief.
The leaves contain parthenolide, a sesquiterpene lactone believed to be the primary active compound, along with other related compounds. Research interest accelerated in the late 20th century after several controlled trials examined feverfew as a migraine preventive, with a Cochrane systematic review later concluding the evidence suggests a modest benefit, while also noting inconsistency across studies and a need for more standardized, higher-quality research.
Feverfew is taken preventively, not as an acute treatment for an active migraine — it's closer in use-pattern to a daily preventive medication than to an as-needed painkiller.
Modulates Serotonin Release
Parthenolide is believed to inhibit excessive serotonin release from platelets, a pathway thought to play a role in migraine onset, though the exact human mechanism is still being studied.
Anti-Inflammatory Activity
Parthenolide also appears to inhibit certain inflammatory signaling pathways (including NF-κB), consistent with feverfew's traditional use for inflammation and fevers.
Reduces Platelet Aggregation
Feverfew has mild antiplatelet effects, contributing both to theories about its migraine mechanism and to the caution around combining it with blood-thinning medications.
Migraine Frequency Reduction
A Cochrane systematic review of controlled trials found feverfew associated with a modest reduction in migraine frequency compared to placebo, making it one of the better-studied herbal options for migraine prevention.
Effect is modest, not dramatic — and trial quality varies
Anti-Inflammatory Support
Consistent with its traditional use, laboratory research shows feverfew's parthenolide content inhibits several inflammatory signaling pathways, supporting its broader traditional reputation beyond migraines.
Largely supported by laboratory rather than large-scale clinical data
Joint & Inflammatory Discomfort (Traditional)
Historically used for arthritis-related discomfort, though this use has considerably less dedicated modern clinical research compared to its migraine application.
Mostly traditional use; modern research focus is migraine-specific
Mild Antiplatelet Activity
Feverfew has demonstrated mild effects on platelet aggregation in research, relevant both to its proposed migraine mechanism and to bleeding-risk safety considerations.
Relevant mainly as a safety consideration with blood thinners
| Use Case | Typical Dose | Notes |
|---|---|---|
| Migraine prevention | 50–150mg daily, standardized extract | Look for products standardized to 0.2-0.4% parthenolide content. |
Timing
Taken daily, consistently, as a preventive measure rather than for acute migraine relief — it will not stop a migraine already underway. Most clinical trials evaluated effectiveness after 4-6 months of continuous use, so it requires patience. Avoid stopping abruptly after long-term use; taper gradually instead.
⚠️ Important Interactions & Cautions
- Blood thinners: Feverfew has mild antiplatelet activity and may increase bleeding risk when combined with anticoagulant or antiplatelet medications.
- Pregnancy: Avoid — feverfew has traditionally been associated with uterine stimulant effects and is not considered safe during pregnancy.
- "Post-feverfew syndrome": Stopping abruptly after long-term regular use has been associated with rebound headaches, anxiety, and joint pain; taper off gradually instead.
- Ragweed/daisy family allergy: Those with allergies to ragweed, chrysanthemums, or related plants (Asteraceae family) may experience cross-reactive allergic reactions.
- Upcoming surgery: Discontinue at least 2 weeks before any scheduled surgery due to bleeding risk.
✅ Generally Safe
- Long history of traditional and modern clinical use
- Well-tolerated in most published trials
- No serious organ toxicity reported in clinical research
Mild Side Effects
- Mouth ulcers or mouth irritation, especially with fresh leaves
- Mild GI upset
- Rebound symptoms if stopped abruptly after long-term use
🧠 Migraine Prevention Stack
- Feverfew (50–150mg daily)
- Magnesium Glycinate — well-studied for migraine frequency
- Riboflavin (Vitamin B2) — supported by clinical research for migraine prevention
A common evidence-informed combination for migraine prevention
🔥 Inflammation Support Stack
- Feverfew (preventive dosing)
- Enhanced Curcumin — complementary anti-inflammatory pathway
- Omega-3 (High EPA) — supports healthy inflammatory response
Avoid combining with blood thinners without medical guidance
The 2004 Cochrane systematic review on feverfew for migraine prevention (updated 2015) assessed six randomised controlled trials and concluded that feverfew is likely more effective than placebo for reducing the frequency of migraine attacks. However, the review also noted that evidence is not uniformly consistent across trials — likely because parthenolide content varies substantially between products and studies used different preparations. The reviewers called for better-standardised, larger-scale trials to confirm the effect size. This remains the most rigorous independent assessment of the evidence to date.
1. Wider B et al. (2015). Feverfew for preventing migraine. Cochrane Database Syst Rev, (4), CD002286.
2. Pareek A et al. (2011). Feverfew (Tanacetum parthenium L.): A systematic review. Pharmacogn Rev, 5(9), 103–110.
3. Johnson ES et al. (1985). Efficacy of feverfew as prophylactic treatment of migraine. Br Med J (Clin Res Ed), 291(6495), 569–573.
All references are peer-reviewed studies or position stands from reputable organizations.
Evidence-based supplement recommendations from a former physical store owner. No hype. No BS. Just facts.
Download Free PDF